Most neuromuscular disorders are rare (orphan) diseases, meaning that fewer than 1 in 2000 people are affected. They all cause a weakening of muscles, which could lead to tremendous disability. Because of this, international collaboration is extremely important to accelerate our knowledge and discovery of new medicines in the field of neuromuscular diseases.
ENMC reviews workshop applications bi-annually in March and September.
Next submission deadline: 1 March 2025. Apply here
NEW: Call for Themed Workshops
In addition to the regular ENMC workshop applications, where topics of the workshops originate from the workshop organisers, ENMC is launching a call for themed workshop applications. This programme prepares the stepping stones for the future by listening to the needs of the neuromuscular field. The two chosen themes are:
1. Challenges of complex drugs and therapies in neuromuscular disorders
2. Artificial intelligence (AI) and/or data sharing in neuromuscular disorders
The submission deadline is: 1 March 2025. Apply here
This is ENMC at a glance:
https://www.enmc.org/wp-content/uploads/2024/05/Approved-WS.jpg
720
1280
ENMC
https://www.enmc.org/wp-content/uploads/2018/07/logo-224x300.png
ENMC2024-05-29 15:04:342024-05-29 15:05:32ENMC approved 7 workshop applications!
https://www.enmc.org/wp-content/uploads/2024/05/Foto-IR-2023-kopie.jpg
1085
1963
ENMC
https://www.enmc.org/wp-content/uploads/2018/07/logo-224x300.png
ENMC2024-05-06 15:27:352024-05-06 15:29:43ENMC Impact Report 2023 is NOW available!
https://www.enmc.org/wp-content/uploads/2024/04/Mission-2024-03-20.png
712
1273
ENMC
https://www.enmc.org/wp-content/uploads/2018/07/logo-224x300.png
ENMC2024-04-04 12:04:162024-04-04 12:05:45Are you the next mentee of 2024? ENMC Mentoring Programme. Deadline July 1st!“The mission of ENMC is to encourage and facilitate communication and collaboration in the field of neuromuscular research with the aim of improving diagnosis and prognosis, finding effective treatments and optimising standards of care to improve the quality of life of people affected by neuromuscular disorders.”
